Literature DB >> 27748065

Intragenic CNVs for epigenetic regulatory genes in intellectual disability: Survey identifies pathogenic and benign single exon changes.

Farah R Zahir1,2, Tracy Tucker3, Sonia Mayo4, Carolyn J Brown5, Emilia L Lim6, Jonathan Taylor5, Marco A Marra6,5, Fadi F Hamdan7, Jacques L Michaud7, Jan M Friedman5.   

Abstract

The disruption of genes involved in epigenetic regulation is well known to cause Intellectual Disability (ID). We reported a custom microarray study that interrogated among others, the epigenetic regulatory gene-class, at single exon resolution. Here we elaborate on identified intragenic CNVs involving epigenetic regulatory genes; specifically discussing those in three genes previously unreported in ID etiology-ARID2, KDM3A, and ARID4B. The changes in ARID2 and KDM3A are likely pathogenic while the ARID4B variant is uncertain. Previously, we found a CNV involving only exon 6 of the JARID2 gene occurred apparently de novo in seven patients. JARID2 is known to cause ID and other neurodevelopmental conditions. However, exon 6 of this gene encodes one of a series of repeated motifs. We therefore, investigated the impact of this variant in two cohorts and present a genotype-phenotype assessment. We find the JARID2 exon 6 CNV is benign, with a high population frequency (>14%), but nevertheless could have a contributory effect. We also present results from an interrogation of the exomes of 2,044 patients with neurocognitive phenotypes for the incidence of potentially damaging mutation in the epigenetic regulatory gene-class. This paper provides a survey of the fine-scale CNV landscape for epigenetic regulatory genes in the context of ID, describing likely pathogenic as well as benign single exon imbalances.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ARID1B; ARID2; ARID4B; CHD6; CHD7; JARID2; JMJDIC; KDM3A; MEF2C; UBE2A; epigenetics; intellectual disability; intragenic CNVs

Mesh:

Substances:

Year:  2016        PMID: 27748065     DOI: 10.1002/ajmg.a.37669

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin-Siris syndrome-like phenotype.

Authors:  Nuria C Bramswig; O Caluseriu; H-J Lüdecke; F V Bolduc; N C L Noel; T Wieland; H M Surowy; H-J Christen; H Engels; T M Strom; D Wieczorek
Journal:  Hum Genet       Date:  2017-01-25       Impact factor: 4.132

Review 2.  Crucial Functions of the JMJD1/KDM3 Epigenetic Regulators in Cancer.

Authors:  Yuan Sui; Ruicai Gu; Ralf Janknecht
Journal:  Mol Cancer Res       Date:  2020-06-30       Impact factor: 6.333

Review 3.  Chromatin Remodeling BAF (SWI/SNF) Complexes in Neural Development and Disorders.

Authors:  Godwin Sokpor; Yuanbin Xie; Joachim Rosenbusch; Tran Tuoc
Journal:  Front Mol Neurosci       Date:  2017-08-03       Impact factor: 5.639

4.  Exon-focused targeted oligonucleotide microarray design increases detection of clinically relevant variants across multiple NHS genomic centres.

Authors:  Jade Heath; Angharad Williams; Jana Jezkova; Deborah Barrell; Jessica Norton; Morag N Collinson; Sarah J Beal; Sian Corrin; Sian Morgan
Journal:  NPJ Genom Med       Date:  2020-07-21       Impact factor: 8.617

5.  Variable neurodevelopmental and morphological phenotypes of carriers with 12q12 duplications.

Authors:  Lynnea Myers; Moira Blyth; Kamran Moradkhani; Dubravka Hranilović; Sam Polesie; Johan Isaksson; Ann Nordgren; Maja Bucan; Marie Vincent; Sven Bölte; Britt-Marie Anderlid; Kristiina Tammimies
Journal:  Mol Genet Genomic Med       Date:  2019-11-15       Impact factor: 2.183

6.  JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome.

Authors:  Eline A Verberne; Shuxiang Goh; Jade England; Mieke M van Haelst; Philippe M Campeau; Manon van Ginkel; Louise Rafael-Croes; Saskia Maas; Abeltje Polstra; Yuri A Zarate; Katherine A Bosanko; Kieran B Pechter; Emma Bedoukian; Kosuke Izumi; Ayeshah Chaudhry; Nathaniel H Robin; Megan Boothe; Natalie C Lippa; Vimla Aggarwal; Darryl C De Vivo; Anna Lehman; Causes Study; Sylvia Stockler; Ange-Line Bruel; Bertrand Isidor; Jennifer Lemons; David F Rodriguez-Buritica; Christopher M Richmond; Zornitza Stark; Pankaj B Agrawal; R Frank Kooy; Marije E C Meuwissen; David A Koolen; Rolf Pfundt; Agne Lieden; Britt-Marie Anderlid; Dagmar Glatz; Marcel M A M Mannens; Madhura Bakshi; Frédérick A Mallette
Journal:  Genet Med       Date:  2020-10-20       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.